Su S, Bao W, Liu Y, Shi P, Manwani D, Murakhovskaya I
Blood. 2024; 145(3):334-347.
PMID: 39656114
PMC: 11775509.
DOI: 10.1182/blood.2024025175.
Zahran A, El-Badawy O, Badawy E, Elsayh K, Gad E, Saad K
J Hematol. 2023; 12(4):161-169.
PMID: 37692868
PMC: 10482610.
DOI: 10.14740/jh1149.
Arthur C, Stowell S
Annu Rev Pathol. 2022; 18:537-564.
PMID: 36351365
PMC: 10414795.
DOI: 10.1146/annurev-pathol-042320-110411.
Hendrickson J
Ann Blood. 2021; 5.
PMID: 33554044
PMC: 7861514.
DOI: 10.21037/aob-2020-scd-01.
Lee J, Madany E, El Kadi N, Pandya S, Ng K, Yamashita M
Front Immunol. 2020; 11:584254.
PMID: 33101313
PMC: 7546415.
DOI: 10.3389/fimmu.2020.584254.
Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model.
Liu D, Gibb D, Escamilla-Rivera V, Liu J, Santhanakrishnan M, Shi Z
Transfusion. 2019; 59(10):3243-3252.
PMID: 31403208
PMC: 6785373.
DOI: 10.1111/trf.15482.
Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance.
Chhetri R, Wee L, Sinha R, Kutyna M, Pham A, Stathopoulos H
Haematologica. 2019; 104(10):e451-e454.
PMID: 30819906
PMC: 6886410.
DOI: 10.3324/haematol.2018.215087.
Transfusion-related red blood cell alloantibodies: induction and consequences.
Tormey C, Hendrickson J
Blood. 2019; 133(17):1821-1830.
PMID: 30808636
PMC: 6484385.
DOI: 10.1182/blood-2018-08-833962.
Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion.
Patel S, Gibb D, Girard-Pierce K, Zhou X, Rodrigues L, Arthur C
Front Immunol. 2018; 9:2516.
PMID: 30505302
PMC: 6250814.
DOI: 10.3389/fimmu.2018.02516.
Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy.
Yee M, Josephson C, Winkler A, Webb J, Luban N, Leong T
Transfusion. 2018; 58(6):1363-1371.
PMID: 29664198
PMC: 6021219.
DOI: 10.1111/trf.14610.
Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.
Patel S, Bennett A, Girard-Pierce K, Maier C, Chonat S, Arthur C
Blood Adv. 2018; 2(2):105-115.
PMID: 29365318
PMC: 5787868.
DOI: 10.1182/bloodadvances.2017010124.
B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice.
Gibb D, Liu J, Santhanakrishnan M, Natarajan P, Madrid D, Patel S
Transfusion. 2017; 57(11):2595-2608.
PMID: 28836263
PMC: 5745367.
DOI: 10.1111/trf.14288.
CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model.
Natarajan P, Liu D, Patel S, Santhanakrishnan M, Beitler D, Liu J
Front Immunol. 2017; 8:907.
PMID: 28824633
PMC: 5545689.
DOI: 10.3389/fimmu.2017.00907.
Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.
Gibb D, Liu J, Natarajan P, Santhanakrishnan M, Madrid D, Eisenbarth S
J Immunol. 2017; 199(3):1041-1050.
PMID: 28630094
PMC: 5568771.
DOI: 10.4049/jimmunol.1700401.
The impact of vaccination on RBC alloimmunization in a murine model.
Natarajan P, Santhanakrishnan M, Tormey C, Hendrickson J
Vox Sang. 2017; 112(6):598-600.
PMID: 28597520
PMC: 5575953.
DOI: 10.1111/vox.12541.
The Nlrp3 Inflammasome Does Not Regulate Alloimmunization to Transfused Red Blood Cells in Mice.
Gibb D, Calabro S, Liu D, Tormey C, Spitalnik S, Zimring J
EBioMedicine. 2016; 9:77-86.
PMID: 27345021
PMC: 4972549.
DOI: 10.1016/j.ebiom.2016.06.008.
Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.
Ryder A, Zimring J, Hendrickson J
Transfus Med Hemother. 2015; 41(6):406-19.
PMID: 25670928
PMC: 4280453.
DOI: 10.1159/000368995.
Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.
Guelsin G, Rodrigues C, Visentainer J, Campos P, Traina F, Gilli S
Blood Transfus. 2014; 13(1):53-8.
PMID: 24960644
PMC: 4317090.
DOI: 10.2450/2014.0332-13.
Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermedia.
Bao W, Zhong H, Yazdanbakhsh K
Transfusion. 2014; 54(11):2880-91.
PMID: 24797509
PMC: 4221584.
DOI: 10.1111/trf.12683.
Study of possible clinical and laboratory predictors of alloimmunization against red blood cell antigens in cancer patients.
Dinardo C, Ito G, Sampaio L, Mendrone Junior A
Rev Bras Hematol Hemoter. 2014; 35(6):414-6.
PMID: 24478608
PMC: 3905824.
DOI: 10.5581/1516-8484.20130123.